Yvonne Greenstreet's Net Worth
$54.7 Million
Who is Yvonne Greenstreet?
Yvonne Greenstreet has an estimated net worth of $54.7 Million. This is based on reported shares across multiple companies, which include ALNYLAM PHARMACEUTICALS, INC., Molecular Insight Pharmaceuticals, Inc., Pacira Pharmaceuticals, Inc., and Moelis & Co.
SEC CIK
Yvonne Greenstreet's CIK is 0001446125
Past Insider Trading and Trends
2018 was Yvonne Greenstreet's most active year for acquiring shares with 21 total transactions. Yvonne Greenstreet's most active month to acquire stocks was the month of May. 2024 was Yvonne Greenstreet's most active year for disposing of shares, totalling 26 transactions. Yvonne Greenstreet's most active month to dispose stocks was the month of July. 2020 saw Yvonne Greenstreet paying a total of $8,765,697.60 for 169,863 shares, this is the most they've acquired in one year. In 2021 Yvonne Greenstreet cashed out on 119,212 shares for a total of $12,155,940.21, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
ALNYLAM PHARMACEUTICALS, INC. (ALNY) Snapshot price: $246.78
Chief Executive Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
$182.50 | -$2,925,000.00 | 73.44K |
Scheduled
|
Aug 20
| ||
Form 4
|
—
|
0
|
$177.50 | -$2,802,380.00 | 73.44K |
Scheduled
|
Aug 1
| ||
Form 4
| -8.81% | -7.09K |
$261.00 | -$1,851,273.00 | 73.44K |
Scheduled
|
Jul 11
| ||
Form 4
| +12.04% | 8.65K |
$230.99 | -$1,917,475.08 | 80.53K |
Jun 24 - Jun 25
| |||
Form 4
| +49.36% | 23.75K |
—
|
—
| 71.88K |
Mar 1
| |||
Form 4
| +6.62% | 2.99K |
$155.31 | -$455,357.07 | 48.13K |
Feb 27 - Feb 28
| |||
Form 4
| +28.18% | 9.92K |
$148.06 | -$1,040,884.56 | 45.14K |
Feb 15 - Feb 16
| |||
Form 4
| +16.10% | 4.88K |
$185.85 | -$753,986.38 | 35.22K |
Aug 3 - Aug 4
| |||
Form 4
| +44.47% | 9.34K |
$194.59 | -$1,481,811.47 | 30.33K |
Apr 26 - Apr 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 27
| |||
Form 4
| +51.02% | 7.09K |
$191.68 | -$1,150,438.83 | 21K |
Aug 3 - Aug 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 31
| |||
Form 4
| +26.12% | 2.88K |
$189.01 | -$479,699.01 | 13.9K |
Dec 21 - Dec 22
| |||
Form 4
|
—
|
0
|
$138.05 | -$6,468,501.60 | 11.02K |
Scheduled
|
Aug 6
| ||
Form 4
| +32.95% | 2.73K |
$131.85 | -$309,977.15 | 11.02K |
Apr 19 - Apr 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 24
| |||
Form 4
| +72.01% | 3.47K |
$155.99 | -$303,403.05 | 8.29K |
Feb 11 - Feb 12
| |||
Form 4
|
—
|
0
|
$101.61 | -$371,187.50 | 4.82K |
Scheduled
|
Jan 12
| ||
Form 4
|
—
|
0
|
$119.05 | -$3,913,012.10 | 4.82K |
Scheduled
|
Jul 10
| ||
Form 4
|
—
|
0
|
$102.07 | -$1,324,252.72 | 4.82K |
Scheduled
|
Jul 9
| ||
Form 4
|
—
|
0
|
$110.52 | -$4,408,759.58 | 4.82K |
Scheduled
|
May 5 - May 6
| ||
Form 4
| +151.57% | 2.9K |
$104.86 | -$263,503.31 | 4.82K |
Apr 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 26
| |||
Form 4
| -69.14% | -4.29K |
$84.93 | -$1,560,028.00 | 1.92K |
Scheduled
|
Feb 7 - Feb 10
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 23
| |||
Form 4
| +224.01% | 4.29K |
$120.61 | -$386,916.88 | 6.21K |
Dec 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 22
| |||
Form 4
|
—
|
0
|
$73.61 | -$527,603.12 | 1.92K |
Scheduled
|
Nov 20
| ||
Form 4
| +14.01% | 50 |
—
|
—
| 407 |
Jul 11 - Aug 6
| |||
Form 4
| +15.91% | 49 |
—
|
—
| 357 |
Apr 9 - Jun 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 27
| |||
Form 4
| -56.61% | -2.50K |
$120.00 | -$300,000.00 | 1.92K |
Scheduled
|
Aug 30
| ||
Form 4
| +1,927.47% | 4.49K |
$90.95 | -$280,489.80 | 4.72K |
Apr 16 - Aug 13
| |||
Form 4
|
∞
| 233 |
$89.38 | -$681,087.66 | 233 |
Scheduled
|
Mar 26
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 19
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Molecular Insight Pharmaceuticals, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 22
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Pacira BioSciences, Inc. (PCRX) Snapshot price: $13.89
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +9.60% | 1.16K |
—
|
—
| 13.25K |
Jun 8
| |||
Form 4
| +9.67% | 1.07K |
—
|
—
| 12.09K |
Jun 9
| |||
Form 4
| +12.91% | 1.26K |
—
|
—
| 11.02K |
Jun 9
| |||
Form 4
| +73.47% | 4.13K |
—
|
—
| 9.76K |
Jun 5
| |||
Form 4
| +16.14% | 782 |
—
|
—
| 5.63K |
Jun 13
| |||
Form 4
| +38.90% | 1.36K |
—
|
—
| 4.84K |
Jun 14
| |||
Form 4
| +74.40% | 1.49K |
—
|
—
| 3.49K |
Jun 15
| |||
Form 4
|
∞
| 2K |
—
|
—
| 2K |
Jun 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 4
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Moelis & Co (MC) Snapshot price: $63.48
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +1.17% | 33.82 |
—
|
—
| 2.92K |
Nov 14
| |||
Form 4
| +3.57% | 111.57 |
—
|
—
| 3.24K |
Sep 12
| |||
Form 4
|
∞
| 2.02K |
—
|
—
| 2.02K |
Jul 2
| |||
Form 4
| +0.80% | 27.61 |
—
|
—
| 3.46K |
May 17
| |||
Form 4
| +3.78% | 135.16 |
—
|
—
| 3.71K |
Mar 7
| |||
Form 4
| +0.81% | 30.63 |
—
|
—
| 3.83K |
Nov 20
| |||
Form 4
| +0.96% | 38.75 |
—
|
—
| 4.07K |
Aug 17
| |||
Form 4
| +2.55% | 63.52 |
—
|
—
| 2.55K |
Jul 6
| |||
Form 4
|
∞
| 2.07K |
—
|
—
| 2.07K |
Jul 1
| |||
Form 4
| +1.02% | 25.16 |
—
|
—
| 2.49K |
May 24
| |||
Form 4
| +0.97% | 23.73 |
—
|
—
| 2.46K |
Mar 17
| |||
Form 4
| +3.72% | 141.8 |
—
|
—
| 3.95K |
Jan 5
| |||
Form 4
| +1.07% | 40.34 |
—
|
—
| 3.81K |
Dec 7
| |||
Form 4
| +1.23% | 45.9 |
—
|
—
| 3.77K |
Sep 6
| |||
Form 4
|
∞
| 1.76K |
—
|
—
| 1.76K |
Jul 1
| |||
Form 4
| +1.13% | 21.88 |
—
|
—
| 1.97K |
Jun 3
| |||
Form 4
| +4.20% | 78.32 |
—
|
—
| 1.94K |
Mar 4
| |||
Form 4
| +1.02% | 18.85 |
—
|
—
| 1.87K |
Dec 8
| |||
Form 4
| +1.10% | 20.14 |
—
|
—
| 1.85K |
Sep 8
| |||
Form 4
|
∞
| 500 |
—
|
—
| 500 |
Jul 10
| |||
Form 4
| +0.67% | 8.81 |
—
|
—
| 1.33K |
Jun 9
| |||
Form 4
| +0.65% | 8.5 |
—
|
—
| 1.32K |
Mar 6
| |||
Form 4
|
∞
| 1.31K |
—
|
—
| 1.31K |
Feb 19
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||